Distinct molecular features of different macroscopic subtypes of colorectal neoplasms

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Konda, Kenichi ^a   Konishi, Kazuo ^a   Yamochi, Toshiko ^a   Ito, Yoichi M ^c   Nozawa, Hisako ^a   Tojo, Masayuki ^a   Shinmura, Kensuke ^a   Kogo, Mari ^b   Katagiri, Atsushi ^a   Kubota, Yutaro ^a   Muramoto, Takashi ^a   Yano, Yuichiro ^a   Kobayashi, Yoshiya ^a   Kihara, Toshihiro ^a   Tagawa, Teppei ^a   Makino, Reiko ^a   Takimoto, Masafumi ^a   Imawari, Michio ^a   Yoshida, Hitoshi ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAF GENE; COLORECTAL CANCER; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; MICROSATELLITE INSTABILITY; MOLECULAR DYNAMICS; MORPHOLOGY; ONCOGENE; ONCOGENE K RAS; PIK3CA GENE; POLYMERASE CHAIN REACTION; PROTEIN DETERMINATION; SIGNAL TRANSDUCTION; TP53 GENE; VERY ELDERLY; ADENOMA; CLASSIFICATION; COHORT ANALYSIS; COLORECTAL TUMOR; DNA METHYLATION; GENETICS; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY;

B RAF KINASE; BRAF PROTEIN, HUMAN; KRAS PROTEIN, HUMAN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; PROTEIN P53; RAS PROTEIN; TP53 PROTEIN, HUMAN;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84905654125     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103822     Document Type: Article

References (58)

1. Morson BC (1968) Precancerous and early malignant lesions of the large intestine. Br J Surg 55: 725-731.
2. Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87: 159-170. (Pubitemid 26358996)
3. Leggett B, Whitehall V (2010) Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138: 2088-2100.
4. Young J, Jass JR (2006) The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev 15: 1778-1784. (Pubitemid 44664248)
5. Snover DC (2011) Update on the serrated pathway to colorectal carcinoma. Hum Pathol 42: 1-10.
6. Bedenne L, Faivre J, Boutron MC, Piard F, Cauvin JM, et al. (1992) Adenoma - carcinoma sequence or "de novo" carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer 69: 883-888.
7. Kudo S (1993) Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy 25: 455-461.
8. Rembacken BJ, Fujii T, Cairns A, Dixon MF, Yoshida S, et al. (2000) Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet 355: 1211-1214. (Pubitemid 30184529)
9. Peyssonnaux C, Eychene A (2001) The Raf/MEK/ERK pathway: new concepts of activation. Biol Cell 93: 53-62. (Pubitemid 33040860)
10. Fujimori T, Satonaka K, Yamamura-Idei Y, Nagasako K, Maeda S (1994) Non-involvement of ras mutations in flat colorectal adenomas and carcinomas. Int J Cancer 57: 51-55. (Pubitemid 24117099)
11. Minamoto T, Sawaguchi K, Mai M, Yamashita N, Sugimura T, et al. (1994) Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Cancer Res 54: 2841-2844. (Pubitemid 24187758)
12. Richter H, Slezak P, Walch A, Werner M, Bracelmann H, et al. (2003) Distinct chromosomal imbalances in nonpolypoid and polypoid colorectal adenomas indicate different genetic pathways in the development of colorectal neoplasms. Am J Pathol 163: 287-294. (Pubitemid 36759613)
13. Yamagata S, Muto T, Uchida Y, Masaki T, Sawada T, et al. (1994) Lower incidence of K-ras codon 12 mutation in flat colorectal adenomas than in polypoid adenomas. Jpn J Cancer Res 85: 147-151. (Pubitemid 24074539)
14. Konishi K, Takimoto M, Kaneko K, Makino R, Hirayama Y, et al. (2006) BRAF mutations and phosphorylation status of mitogen-activated protein kinases in the development of flat and depressed-type colorectal neoplasias. Br J Cancer 94: 311-317. (Pubitemid 43151553)
15. An B, Kondo Y, Okamoto Y, Shinjo K, Kanemitsu Y, et al. (2010) Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers. Int J Cancer 127: 2095-2105.
16. Minamoto T, Sawaguchi K, Ohta T, Itoh T, Mai M (1994) Superficial-type adenomas and adenocarcinomas of the colon and rectum: a comparative morphological study. Gastroenterology 106: 1436-1443. (Pubitemid 24163111)
17. Hiraoka S, Kato J, Tatsukawa M, Harada K, Fujita H, et al. (2006) Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations. Gastroenterology 131: 379-389. (Pubitemid 44142442)
18. Kaneko K, Kurahashi T, Makino R, Konishi K, Mitamura K (2000) Growth patterns of superficially elevated neoplasia in the large intestine. Gastrointest Endosc 51: 443-450. (Pubitemid 30204765)
19. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 58: S3-43.
20. Kudo S, Kashida H, Nakajima T, Tamura S, Nakajo K (1997) Endoscopic diagnosis and treatment of early colorectal cancer. World J Surg 21: 694-701. (Pubitemid 27369111)
21. Konishi K, Kaneko K, Kurahashi T, Yamamoto T, Kushima M, et al. (2003) A comparison of magnifying and nonmagnifying colonoscopy for diagnosis of colorectal polyps: A prospective study. Gastrointest Endosc 57: 48-53. (Pubitemid 36236798)
22. Kudo S, Tamura S, Nakajima T, Yamano H, Kusaka H, et al. (1996) Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 44: 8-14. (Pubitemid 26268652)
23. Clark SJ, Harrison J, Paul CL, Frommer M (1994) High sensitivity mapping of methylated cytosines. Nucleic Acids Res 22: 2990-2997. (Pubitemid 24260626)
24. Konishi K, Shen L, Wang S, Meltzer SJ, Harpaz N, et al. (2007) Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. Gastroenterology 132: 1254-1260. (Pubitemid 46627571)
25. Konishi K, Shen L, Jelinek J, Watanabe Y, Ahmed S, et al. (2009) Concordant DNA methylation in synchronous colorectal carcinomas. Cancer Prev Res (Phila) 2: 814-822.
26. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, et al. (2007) Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A 104: 18654-18659. (Pubitemid 350210752)
27. Issa JP (2004) CpG island methylator phenotype in cancer. Nat Rev Cancer 4:988-993.
28. Nosho K, Kawasaki T, Ohnishi M, Suemoto Y, Kirkner GJ, et al. (2008) PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations. Neoplasia 10: 534-541. (Pubitemid 351770297)
29. Ogino S, Meyerhardt JA, Cantor M, Brahmandam M, Clark JW, et al. (2005) Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer. Clin Cancer Res 11: 6650-6656. (Pubitemid 41339006)
30. Spittle C, Ward MR, Nathanson KL, Gimotty PA, Rappaport E, et al. (2007) Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanoma. J Mol Diagn 9: 464-471. (Pubitemid 47434113)
31. Konishi K, Yamochi T, Makino R, Kaneko K, Yamamoto T, et al. (2004) Molecular differences between sporadic serrated and conventional colorectal adenomas. Clin Cancer Res 10: 3082-3090. (Pubitemid 38619687)
32. Adachi M, Muto T, Okinaga K, Morioka Y (1991) Clinicopathologic features of the flat adenoma. Dis Colon Rectum 34: 981-986.
33. O'Brien M J, Winawer SJ, Zauber AG, Bushey MT, Sternberg SS, et al. (2004) Flat adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially or during surveillance? Clin Gastroenterol Hepatol 2: 905-911. (Pubitemid 39335797)
34. Morita T, Tomita N, Ohue M, Sekimoto M, Yamamoto H, et al. (2002) Molecular analysis of diminutive, flat, depressed colorectal lesions: are they precursors of polypoid adenoma or early stage carcinoma? Gastrointest Endosc 56: 663-671. (Pubitemid 36531700)
35. Sugimoto T, Ohta M, Ikenoue T, Yamada A, Tada M, et al. (2010) Macroscopic morphologic subtypes of laterally spreading colorectal tumors showing distinct molecular alterations. Int J Cancer 127: 1562-1569.
36. Takahashi T, Nosho K, Yamamoto H, Mikami M, Taniguchi H, et al. (2007) Flat-type colorectal advanced adenomas (laterally spreading tumors) have different genetic and epigenetic alterations from protruded-type advanced adenomas. Mod Pathol 20: 139-147. (Pubitemid 44967959)
37. Voorham QJ, Carvalho B, Spiertz AJ, Claes B, Mongera S, et al. (2012) Comprehensive mutation analysis in colorectal flat adenomas. PLoS One 7: e41963.
38. Kudo S, Kashida H, Tamura T, Kogure E, Imai Y, et al. (2000) Colonoscopic diagnosis and management of nonpolypoid early colorectal cancer. World J - Surg 24: 1081-1090.
39. Saito Y, Fujii T, Kondo H, Mukai H, Yokota T, et al. (2001) Endoscopic treatment for laterally spreading tumors in the colon. Endoscopy 33: 682-686. (Pubitemid 32725160)
40. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, et al. (2008) A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 100: 1734-1738.
41. Yano Y, Konishi K, Yamochi T, Katagiri A, Nozawa H, et al. (2011) Clinicopathological and molecular features of colorectal serrated neoplasias with different mucosal crypt patterns. Am J Gastroenterol 106: 1351-1358.
42. Ogino S, Kawasaki T, Kirkner GJ, Loda M, Fuchs CS (2006) CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn 8: 582-588. (Pubitemid 44774157)
43. Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, et al. (2012) Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 22: 271-282.
44. Yagi K, Akagi K, Hayashi H, Nagae G, Tsuji S, et al. (2010) Three DNA methylation epigenotypes in human colorectal cancer. Clin Cancer Res 16: 21-33.
45. Rodriguez J, Frigola J, Vendrell E, Risques RA, Fraga MF, et al. (2006) Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res 66: 8462-9468.
46. Yang AS, Estecio MR, Doshi K, Mason JB, Mannari RK, et al. (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 32: e38.
47. Matsuzaki K, Deng G, Tanaka H, Kakar S, Miura S, et al. (2005) The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer. Clin Cancer Res 11: 8564-8569. (Pubitemid 43005901)
48. Mollevi DG, Serrano T, Ginesta MM, Valls J, Torras J, et al. (2007) Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection. Carcinogenesis 28: 1241-1246. (Pubitemid 47062683)
49. Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, et al. (2012) Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61: 847-854.
50. Phipps AI, Buchanan DD, Makar KW, Burnett-Hartman AN, Coghill AE, et al. (2012) BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics. Cancer Epidemiol Biomarkers Prev 21: 1792-1798.
51. Konishi K, Issa JP (2007) Targeting aberrant chromatin structure in colorectal carcinomas. Cancer J 13: 49-55.
52. Yamamoto E, Suzuki H, Yamano HO, Maruyama R, Nojima M, et al. (2012) Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype. Am J Pathol 181: 1847-1861.
53. Beggs AD, Jones A, El-Bahwary M, Abulafi M, Hodgson SV, et al. (2012) Whole-genome methylation analysis of benign and malignant colorectal tumours. J Pathol 229: 697-704.
54. Suzuki H, Takatsuka S, Akashi H, Yamamoto E, Nojima M, et al. (2011) Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer. Cancer Res 71: 5646-5658.
55. Liao X, Lochhead P, Nishihara R, Morikawa T, Kuchiba A, et al. (2012) Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 367: 1596-1606.
56. Kaji E, Kato J, Suzuki H, Akita M, Horii J, et al. (2011) Analysis of K-ras, BRAF, and PIK3CA mutations in laterally-spreading tumors of the colorectum. J Gastroenterol Hepatol 26: 599-607.
57. Barault L, Veyrie N, Jooste V, Lecorre D, Chapusot C, et al. (2008) Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers. Int J Cancer 122: 2255-2259. (Pubitemid 351542328)
58. Ogino S, Liao X, Imamura Y, Yamauchi M, McCleary NJ, et al. (2013) Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial. J Natl Cancer Inst 105: 1789-1798.